Colgate-Palmolive sales miss on strong dollar, weak LatAm demand
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
UBS Remains Neutral Following Colgate-Palmolive's (CL) 4Q Earnings Report
February 1, 2016 8:43 AM ESTUBS maintained a Neutral rating on Colgate-Palmolive Company (NYSE: CL), and cut the price target to $67.00 (from $69.00), following the company's 4Q earnings report. CL delivered adjusted Q4 EPS of $0.73, $0.01 ahead of consensus. On the positive, CL's 2016 outlook implies a stronger underlying year ahead as... More



